暂无公司简介
$14.81-0.87%
报价 2026-11-13
市值
$1.42B
EV
$2.32B
PE (TTM)
–
预期 PE (FY2026)
21.8x
52 周区间距高点 -7.1%
$9.88$15.95
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
电话会信号
辅助标签Q3 20262026-11-10
扩产AI 词频高
指引 有升有降
信心 4
分析师 3
“We are targeting hospital outpatient imaging centers, a $44 billion incremental opportunity, bringing our total addressable market to roughly $77 billion.”
原文引用(1)
- 扩产:our strong operating cash flows support our choosing to lean in modestly more. On CapEx in the second half of 2026
蓝色标签在暴涨研究中略有区分度;悬停查看口径。
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Medical - Devices| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| LMRILumexa Imaging Holdings, Inc. Common Stock | $1.42B | -0.9% | +4.9% | 17.1% | – | 21.4x | 26.5x | |
| INSPInspire Medical Systems, Inc. | $1.77B | +0.9% | -5.8% | 85.5% | 14.8x | 22.8x | 17.1x | |
| BFLYButterfly Network, Inc. | $1.63B | -8.8% | +36.0% | 73% | – | – | – | 高增长 |
| CNMDCONMED Corporation | $1.51B | +0.2% | -0.4% | 56.4% | 21.0x | 10.8x | 11.4x | |
| TNDMTandem Diabetes Care, Inc. | $1.4B | +14.6% | +7.6% | 56.5% | – | – | – | |
| PRCTPROCEPT BioRobotics Corporation | $1.37B | +1.2% | +21.1% | 66.3% | – | – | – | |
| IARTIntegra LifeSciences Holdings Corporation | $1.12B | +0.3% | +0.8% | 51% | 88.0x | 12.4x | 16.0x | |
| ATECAlphatec Holdings, Inc. | $1.1B | +0.1% | +13.4% | 71.5% | – | 51.2x | 232.0x | GARP |
| IRMDIRadimed Corporation | $1.09B | +0.4% | +11.5% | 76.8% | 56.2x | 42.1x | 42.1x | |
| 同行中位数 | – | – | +9.5% | 68.9% | 38.6x | 22.8x | 17.1x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-09-30 Q3 2026 | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $272M | $264.2M | $252.5M | $267.7M | $258.9M | $251.4M | $245M | $248M |
| Gross Margin | 17.1% | 10.9% | 9.8% | 11.1% | 15.3% | 15.6% | 14.9% | 8.7% |
| Operating Margin | 1.9% | 1.7% | 1.8% | -2.8% | 5% | 4.4% | 4.1% | 6.1% |
| Net Income | $7.2M | $2.7M | $1.7M | $-28.7M | $-3.5M | $-7.2M | $-7.7M | $-25.1M |
| Diluted EPS | 0.07 | 0.03 | 0.02 | -0.38 | -0.04 | -0.08 | -0.08 | -0.26 |
| Operating Cash Flow | $34.8M | $32.8M | $2.9M | $17.1M | $11.9M | $2.1M | $-14M | $25.3M |